Overview

Study of Lupron Depot In The Treatment of Central Precocious Puberty

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Lupron (leuprolide acetate) is safe and effective in treating children with Central Precocious Puberty (CPP), and to assess long term effects of leuprolide acetate treatment after therapy is discontinued.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott
Treatments:
Leuprolide